Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC
ClinicalTrials.gov study NCT03418532. IPD Sharing: NO. Countries: 1. Publications: 0.
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
ClinicalTrials.gov study NCT06247280. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NS
ClinicalTrials.gov study NCT06305754. IPD Sharing: YES. Countries: 19. Publications: 0.
Bevacizumab Combined With Double Dose Icotinib in Patients With EGFR Exon 21-L858R Mutation
ClinicalTrials.gov study NCT05263947. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02503722. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response
ClinicalTrials.gov study NCT01523340. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
ClinicalTrials.gov study NCT05503667. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06838273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
ClinicalTrials.gov study NCT04830826. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation
ClinicalTrials.gov study NCT03856697. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations
ClinicalTrials.gov study NCT06362980. IPD Sharing: NO. Countries: 1. Publications: 0.
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
ClinicalTrials.gov study NCT01665417. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06383728. IPD Sharing: NO. Countries: 1. Publications: 0.
Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients
ClinicalTrials.gov study NCT03171636. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge
ClinicalTrials.gov study NCT04335292. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib for NSCLC With Uncommon EGFR Mutations
ClinicalTrials.gov study NCT05421936. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)
ClinicalTrials.gov study NCT01790217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05401110. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion Mutation
ClinicalTrials.gov study NCT04063462. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
ClinicalTrials.gov study NCT05146219. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.